These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6980682)

  • 1. Characteristics of Haemophilus ducreyi. A study.
    Sng EH; Lim AL; Rajan VS; Goh AJ
    Br J Vener Dis; 1982 Aug; 58(4):239-42. PubMed ID: 6980682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro susceptibility of thirty strains of Haemophilus ducreyi to several antibiotics including six cephalosporins.
    Sanson-Le Pors MJ; Casin I; Ortenberg M; Perol Y
    J Antimicrob Chemother; 1983 Mar; 11(3):271-80. PubMed ID: 6601649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi.
    Aldridge KE; Cammarata C; Martin DH
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1986-8. PubMed ID: 8239617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the in vitro activity of rosamicin, erythromycin, clindamycin, metroidazole and ornidazole against Haemophilus ducreyi, including beta-lactamase producing strains.
    Feltham S; Ronald AR; Albritton WL
    J Antimicrob Chemother; 1979 Nov; 5(6):731-4. PubMed ID: 317079
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibiotic susceptibilities and plasmid profiles of Haemophilus ducreyi isolates from southern Africa.
    Abeck D; Johnson AP; Dangor Y; Ballard RC
    J Antimicrob Chemother; 1988 Oct; 22(4):437-44. PubMed ID: 3264554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibilities of southern African isolates of Haemophilus ducreyi.
    Dangor Y; Miller SD; Exposto Fda L; Koornhof HJ
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1458-60. PubMed ID: 3264133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility of Haemophilus ducreyi.
    Hammond GW; Lian CJ; Wilt JC; Ronald AR
    Antimicrob Agents Chemother; 1978 Apr; 13(4):608-12. PubMed ID: 307364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of U-63366, a spectinomycin analog; roxithromycin (RU 28965), a new macrolide antibiotic; and five quinolone derivatives against Haemophilus ducreyi.
    Sanson-Le Pors MJ; Casin IM; Thebault MC; Arlet G; Perol Y
    Antimicrob Agents Chemother; 1986 Sep; 30(3):512-3. PubMed ID: 2946262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of Haemophilus ducreyi in culture.
    Sturm AW; Zanen HC
    J Clin Microbiol; 1984 May; 19(5):672-4. PubMed ID: 6610690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selenium and the growth of Haemophilus ducreyi.
    Vanden Berghe DA
    J Clin Pathol; 1987 Oct; 40(10):1174-7. PubMed ID: 3500188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between in vitro antimicrobial susceptibilities and beta-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States.
    Motley M; Sarafian SK; Knapp JS; Zaidi AA; Schmid G
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1639-43. PubMed ID: 1416845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of Haemophilus ducreyi to spectinomycin in vitro.
    Hafiz S; Jones BM; Kinghorn GR; Duerden BI
    Genitourin Med; 1986 Aug; 62(4):251-2. PubMed ID: 2942458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of antimicrobial susceptibility patterns of fifty-seven strains of Haemophilus ducreyi isolated in Amsterdam from 1978 to 1985.
    Sturm AW
    J Antimicrob Chemother; 1987 Feb; 19(2):187-91. PubMed ID: 3494720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance of Haemophilus ducreyi.
    Rutanarugsa A; Vorachit M; Polnikorn N; Jayanetra P
    Southeast Asian J Trop Med Public Health; 1990 Jun; 21(2):185-93. PubMed ID: 2237585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility of 103 strains of Haemophilus ducreyi isolated in Johannesburg.
    Bilgeri YR; Ballard RC; Duncan MO; Mauff AC; Koornhof HJ
    Antimicrob Agents Chemother; 1982 Oct; 22(4):686-8. PubMed ID: 6983858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of Haemophilus ducreyi to several antibiotics.
    Ismaeel NA
    Microbios; 1993; 74(299):103-9. PubMed ID: 8361391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of 40 Haemophilus ducreyi strains to 34 antimicrobial products.
    Slootmans L; Vanden Berghe DA; Van Dyck E; Piot P
    Antimicrob Agents Chemother; 1983 Oct; 24(4):564-7. PubMed ID: 6606394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and identification of Haemophilus ducreyi in a clinical study.
    Sottnek FO; Biddle JW; Kraus SJ; Weaver RE; Stewart JA
    J Clin Microbiol; 1980 Aug; 12(2):170-4. PubMed ID: 6971872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Importance of culture media choice in the isolation of Haemophilus ducreyi. Experience in Senegal].
    Dieng Sarr A; Toure Kane NC; Samb ND; Boye CS; Diaw IK; Diouf G; N'Doye I; M'Boup S
    Bull Soc Pathol Exot; 1994; 87(1):22-7. PubMed ID: 8003900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Haemophilus ducreyi in the clinical laboratory.
    Nobre GN
    J Med Microbiol; 1982 May; 15(2):243-5. PubMed ID: 6754945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.